FDA greenlights TomoTherapy TomoDirect system

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

TomoTherapy has received FDA 510(k) clearance for its TomoDirect radiation therapy technology for its Hi-Art treatment system.

With its discrete-angle, sliding-beam delivery mode, TomoDirect allows clinicians to choose several discrete angles, as well as the optimal modulation level required for delivery, including whole breast irradiation and palliative treatments, according to the Madison, Wis.-based TomoTherapy.